FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Evemie Schutyser

Research Profile

Chemicals & Drugs

Physiology

Anatomy

Co-author Network

Publications

TOP 3
Hannelien Verbeke; Gert De Hertogh; Sandra Li; Jo Vandercappellen; Samuel Noppen; Evemie Schutyser; Ahmed Abu El-Asrar; Ghislain Opdenakker; Jo Van Damme; Karel Geboes; Sofie Struyf
Expression of angiostatic platelet factor-4var/CXCL4L1 counterbalances angiogenic impulses of vascular endothelial growth factor, interleukin-8/CXCL8, and stromal cell-derived factor 1/CXCL12 in esophageal and colorectal cancer.
Katleen Michiels; Evemie Schutyser; René Conings; Jean-Pierre Lenaerts; Willy Put; Sandra Nuyts; Pierre Delaere; Reinhilde Jacobs; Sofie Struyf; Paul Proost; Jo Van Damme
Carcinoma cell-derived chemokines and their presence in oral fluid.
Paul Proost; Tamara Loos; Anneleen Mortier; Evemie Schutyser; Mieke Gouwy; Samuel Noppen; Chris Dillen; Isabelle Ronsse; René Conings; Sofie Struyf; Ghislain Opdenakker; Prabhat C Maudgal; Jo Van Damme
Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Evemie Schutyser (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Hannelien Verbeke; Gert De Hertogh; Sandra Li; Jo Vandercappellen; Samuel Noppen; Evemie Schutyser; Ahmed Abu El-Asrar; Ghislain Opdenakker; Jo Van Damme; Karel Geboes; Sofie Struyf
Expression of angiostatic platelet factor-4var/CXCL4L1 counterbalances angiogenic impulses of vascular endothelial growth factor, interleukin-8/CXCL8, and stromal cell-derived factor 1/CXCL12 in esophageal and colorectal cancer.
Human pathology 2010;41(7):990-1001.
2009: Katleen Michiels; Evemie Schutyser; René Conings; Jean-Pierre Lenaerts; Willy Put; Sandra Nuyts; Pierre Delaere; Reinhilde Jacobs; Sofie Struyf; Paul Proost; Jo Van Damme
Carcinoma cell-derived chemokines and their presence in oral fluid.
European journal of oral sciences 2009;117(4):362-8.
2008: Paul Proost; Tamara Loos; Anneleen Mortier; Evemie Schutyser; Mieke Gouwy; Samuel Noppen; Chris Dillen; Isabelle Ronsse; René Conings; Sofie Struyf; Ghislain Opdenakker; Prabhat C Maudgal; Jo Van Damme
Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation.
The Journal of experimental medicine 2008;205(9):2085-97.
2008: Mieke Gouwy; Sofie Struyf; Samuel Noppen; Evemie Schutyser; Jean-Yves Springael; Marc Parmentier; Paul Proost; Jo Van Damme
Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events.
Molecular pharmacology 2008;74(2):485-95.
2007: Jo Vandercappellen; Samuel Noppen; Hannelien Verbeke; Willy Put; René Conings; Mieke Gouwy; Evemie Schutyser; Paul Proost; Raf Sciot; Karel Geboes; Ghislain Opdenakker; Jo Van Damme; Sofie Struyf
Stimulation of angiostatic platelet factor-4 variant (CXCL4L1/PF-4var) versus inhibition of angiogenic granulocyte chemotactic protein-2 (CXCL6/GCP-2) in normal and tumoral mesenchymal cells.
Journal of leukocyte biology 2007;82(6):1519-30.
2007: Paul Proost; Anneleen Mortier; Tamara Loos; Jo Vandercappellen; Mieke Gouwy; Isabelle Ronsse; Evemie Schutyser; Willy Put; Marc Parmentier; Sofie Struyf; Jo Van Damme
Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration.
Blood 2007;110(1):37-44.
2007: Evemie Schutyser; Yingjun Su; Yingchun Yu; Mieke Gouwy; Snjezana Zaja-Milatovic; Jo Van Damme; Ann Richmond
Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cells.
European cytokine network 2007;18(2):59-70.
2006: Tamara Loos; Lies Dekeyzer; Sofie Struyf; Evemie Schutyser; Klara Gijsbers; Mieke Gouwy; Annelies Fraeyman; Willy Put; Isabelle Ronsse; Bernard Grillet; Ghislain Opdenakker; Jo Van Damme; Paul Proost
TLR ligands and cytokines induce CXCR3 ligands in endothelial cells: enhanced CXCL9 in autoimmune arthritis.
Laboratory investigation; a journal of technical methods and pathology 2006;86(9):902-16.
2006: Yukiko Ueda; Nicole F Neel; Evemie Schutyser; Dayanidhi Raman; Ann Richmond
Deletion of the COOH-terminal domain of CXC chemokine receptor 4 leads to the down-regulation of cell-to-cell contact, enhanced motility and proliferation in breast carcinoma cells.
Cancer research 2006;66(11):5665-75.
2006: Paul Proost; Sofie Struyf; Tamara Loos; Mieke Gouwy; Evemie Schutyser; René Conings; Isabelle Ronsse; Marc Parmentier; Bernard Grillet; Ghislain Opdenakker; Jan Balzarini; Jo Van Damme
Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies.
Arthritis research & therapy 2006;8(4):R107.
2005: Nicole F Neel; Evemie Schutyser; Jiqing Sai; Guo-Huang Fan; Ann Richmond
Chemokine receptor internalization and intracellular trafficking.
Cytokine & growth factor reviews 2005;16(6):637-58.
2005: Evemie Schutyser; Ann Richmond; Jo Van Damme
Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes.
Journal of leukocyte biology 2005;78(1):14-26.
2004: Paul Proost; Sara Verpoest; Kirsten Van de Borne; Evemie Schutyser; Sofie Struyf; Willy Put; Isabelle Ronsse; Bernard Grillet; Ghislain Opdenakker; Jo Van Damme
Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids.
Journal of leukocyte biology 2004;75(5):777-84.
2004: Paul Proost; Frank Mahieu; Evemie Schutyser; Jo Van Damme
Posttranslational processing of chemokines.
Methods in molecular biology (Clifton, N.J.) 2004;239():27-44.
2003: Sofie Struyf; Evemie Schutyser; Mieke Gouwy; Klara Gijsbers; Paul Proost; Yves Benoit; Ghislain Opdenakker; Jo Van Damme; Geneviève Laureys
PARC/CCL18 is a plasma CC chemokine with increased levels in childhood acute lymphoblastic leukemia.
The American journal of pathology 2003;163(5):2065-75.
2003: Evemie Schutyser; Sofie Struyf; Jo Van Damme
The CC chemokine CCL20 and its receptor CCR6.
Cytokine & growth factor reviews 2003;14(5):409-26.
2003: Anja Wuyts; Sofie Struyf; Klara Gijsbers; Evemie Schutyser; Willy Put; René Conings; Jean-Pierre Lenaerts; Karel Geboes; Ghislain Opdenakker; Patricia Menten; Paul Proost; Jo Van Damme
The CXC chemokine GCP-2/CXCL6 is predominantly induced in mesenchymal cells by interleukin-1beta and is down-regulated by interferon-gamma: comparison with interleukin-8/CXCL8.
Laboratory investigation; a journal of technical methods and pathology 2003;83(1):23-34.
2002: Evemie Schutyser; Sofie Struyf; Paul Proost; Ghislain Opdenakker; Geneviève Laureys; Bruno Verhasselt; Lieven Peperstraete; Ignace Van de Putte; Alessandra Saccani; Paola Allavena; Alberto Mantovani; Jo Van Damme
Identification of biologically active chemokine isoforms from ascitic fluid and elevated levels of CCL18/pulmonary and activation-regulated chemokine in ovarian carcinoma.
The Journal of biological chemistry 2002;277(27):24584-93.
2001: Paul Proost; Evemie Schutyser; Patricia Menten; Sofie Struyf; Anja Wuyts; Ghislain Opdenakker; Michel detheux; Marc Parmentier; Christine Durinx; Anne-Marie Lambeir; J Neyts; Sandra Liekens; P C Maudgal; An D Billiau; Jo Van Damme
Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties.
Blood 2001;98(13):3554-61.
2001: Evemie Schutyser; Sofie Struyf; Anja Wuyts; Willy Put; Karel Geboes; Bernard Grillet; Ghislain Opdenakker; Jo Van Damme
Selective induction of CCL18/PARC by staphylococcal enterotoxins in mononuclear cells and enhanced levels in septic and rheumatoid arthritis.
European journal of immunology 2001;31(12):3755-62.
2001: Sofie Struyf; G Stoops; Els Van Coillie; Mieke Gouwy; Evemie Schutyser; Jean-Pierre Lenaerts; Pierre Fiten; Ilse Van Aelst; Paul Proost; Ghislain Opdenakker; Jo Van Damme
Gene cloning of a new plasma CC chemokine, activating and attracting myeloid cells in synergy with other chemoattractants.
Biochemistry 2001;40(39):11715-22.
2000: Anja Wuyts; Evemie Schutyser; Patricia Menten; Sofie Struyf; A D'Haese; Hidde Bult; Ghislain Opdenakker; Paul Proost; Jo Van Damme
Biochemical and biological characterization of neutrophil chemotactic protein, a novel rabbit CXC chemokine from alveolar macrophages.
Biochemistry 2000;39(47):14549-57.
2000: Evemie Schutyser; Sofie Struyf; Patricia Menten; Jean-Pierre Lenaerts; René Conings; Willy Put; Anja Wuyts; Paul Proost; Jo Van Damme
Regulated production and molecular diversity of human liver and activation-regulated chemokine/macrophage inflammatory protein-3 alpha from normal and transformed cells.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(8):4470-7.
2000: Paul Proost; Patricia Menten; Sofie Struyf; Evemie Schutyser; Ingrid De Meester; Jo Van Damme
Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78beta into a most efficient monocyte attractant and CCR1 agonist.
Blood 2000;96(5):1674-80.
1999: Patricia Menten; Sofie Struyf; Evemie Schutyser; Anja Wuyts; Erik De Clercq; Dominique Schols; Paul Proost; Jo Van Damme
The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine.
The Journal of clinical investigation 1999;104(4):R1-5.